Clinical Associations of Osteoporosis in BCR::ABL1 Negative Myeloproliferative Neoplasms
Authors:
- Mürüvvet Seda AydinMAMürüvvet Seda Aydin
- Simten DagdasSDSimten Dagdas
- Mehmet Sezgin PepelerMPMehmet Sezgin Pepeler
- Gülten KorkmazGKGülten Korkmaz
- Aysel AlperAAAysel Alper
- Elif AçıkgözEAElif Açıkgöz
- Tugce Nur BektasTBTugce Nur Bektas
- Merve PamukçuoğluMPMerve Pamukçuoğlu
- Funda CeranFCFunda Ceran
- Gulsum OzetGOGulsum Ozet
Open Access
- 1 January 2026
- journal article
- Published by Wiley in International Journal of Endocrinology
- Vol. 2026 (1) , 6041016
Abstract
Background/Aim: Osteoporosis can be seen in some hematologic diseases, such as BCR::ABL1‐negative myeloproliferative neoplasms. The incidence and prevalence of osteoporosis and osteopenia in BCR::ABL1‐negative MPN are not very well known. Materials and Methods: Patients diagnosed with one of the classical BCR::ABL1‐negative myeloproliferative neoplasms, such as essential thrombocythemia, polycythemia vera, and myelofibrosis, were included in the study. Due to the retrospective design, a matched control group was not available, and comparisons with the general population were made for contextual interpretation. Results: Ninety‐four patients were included. Fifty‐eight (61.7%) patients had osteopenia, and 16 (17%) patients had osteoporosis according to femoral dual energy X‐ray absorptiometry (DXA) measurements. Fifty‐three (58.9%) patients had osteopenia, and 27 (30%) patients had osteoporosis according to lumbar DXA measurements. When both femur and lumbar DXA measurements were evaluated together, 67 (71.3%) patients had osteopenia and 31 (33%) patients had osteoporosis. In patients over 50 years of age, these frequencies were found to be 71.4% for osteopenia and 37.7% for osteoporosis. Osteopenia was significantly associated with female sex, cytoreduction, and longer disease duration ( p < 0.05). In the multivariate analysis, female sex was found to be an independent risk factor for osteopenia ( p = 0.009, OR: 3.70, 95% CI: 1.394–9.833). Osteoporosis was significantly associated with disease subtype, female sex, age, and no antiaggregant use ( p < 0.05). In the multivariate analysis, older age ( p = 0.044, OR: 1.04, 95% CI: 1.001–1.083) was found to be an independent risk factor for osteoporosis. Conclusion: Patients with BCR::ABL1‐negative classical myeloproliferative neoplasms have a higher risk of osteopenia/osteoporosis compared to the general population. DXA measurements should be performed, especially in female patients and in patients of advanced age.Keywords
This publication has 15 references indexed in Scilit:
- The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic NeoplasmsLeukemia, 2022
- UK clinical guideline for the prevention and treatment of osteoporosisArchives of Osteoporosis, 2022
- Highly increased risk of fracture in patients with myeloproliferative neoplasmLeukemia & Lymphoma, 2020
- MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and AlgeriaCancer Medicine, 2020
- MPN10 score and survival of molecularly annotated myeloproliferative neoplasm patientsLeukemia & Lymphoma, 2017
- Bone mineral density and microarchitecture in patients with essential thrombocythemia and polycythemia veraOsteoporosis International, 2016
- Bone morbidity in chronic myeloproliferative neoplasmsExpert Review of Hematology, 2015
- Bone geometry, bone mineral density, and micro-architecture in patients with myelofibrosis: a cross-sectional study using DXA, HR-pQCT, and bone turnover markersInternational Journal of Hematology, 2015
- Chronic myeloproliferative neoplasms and risk of osteoporotic fractures; a nationwide population‐based cohort studyBritish Journal of Haematology, 2013
- Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNsJournal of Clinical Oncology, 2012